Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI) -- Ignore unavailable to you. Want to Upgrade?

To: OldAIMGuy who wrote (1144)	11/27/2006 11:25:14 AM
From: tuck	Read Replies (1) \| Respond to of 1154

>>8:34AM Oscient Pharma (OSCID) says FDA accepts as "Complete Response'' OSCI's submission following Factive approvable letter for 5-day CAP (OSCI) 6.58 : OSCID says the FDA has accepted as complete it's response to the Factive tablets approvable letter for the application seeking approval for the five-day treatment of community-acquired pneumonia of mild to moderate severity. Factive is currently approved by the FDA for the five-day treatment of acute exacerbations of chronic bronchitis and the seven-day treatment of CAP.<< Courtesy of Briefing.com. Not sure what their odds are of changing the FDA's mind, but it's good for a few pennies in today's very negative market. Obviously, approval would be huge. Cheers, Tuck